| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | IGv | 1.01e-06 | 75 | 83 | 6 | SM00406 | |
| Domain | Growth_fac_rcpt_ | 6.85e-05 | 156 | 83 | 6 | IPR009030 | |
| Domain | IG | 1.04e-04 | 421 | 83 | 9 | SM00409 | |
| Domain | Ig_sub | 1.04e-04 | 421 | 83 | 9 | IPR003599 | |
| Domain | TM_Fragile-X-F-assoc | 1.16e-04 | 4 | 83 | 2 | IPR019396 | |
| Domain | Tmemb_185A | 1.16e-04 | 4 | 83 | 2 | PF10269 | |
| Domain | - | HSPG2 BTN3A3 EPHA6 HMCN1 PDGFRA KALRN BTNL2 FNDC3A BTN3A2 BTN3A1 MILR1 | 1.64e-04 | 663 | 83 | 11 | 2.60.40.10 |
| Domain | EGF_CA | 2.12e-04 | 122 | 83 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.28e-04 | 124 | 83 | 5 | IPR001881 | |
| Domain | EGF | 2.46e-04 | 126 | 83 | 5 | PF00008 | |
| Domain | Ig_V-set | 2.59e-04 | 199 | 83 | 6 | IPR013106 | |
| Domain | Ig-like_fold | HSPG2 BTN3A3 EPHA6 HMCN1 PDGFRA KALRN BTNL2 FNDC3A BTN3A2 BTN3A1 MILR1 | 2.82e-04 | 706 | 83 | 11 | IPR013783 |
| Domain | IG_LIKE | 3.27e-04 | 491 | 83 | 9 | PS50835 | |
| Domain | Ig-like_dom | 3.89e-04 | 503 | 83 | 9 | IPR007110 | |
| Domain | Clathrin | 4.04e-04 | 7 | 83 | 2 | PF00637 | |
| Domain | CHCR | 4.04e-04 | 7 | 83 | 2 | PS50236 | |
| Domain | Znf_FYVE_PHD | 5.00e-04 | 147 | 83 | 5 | IPR011011 | |
| Domain | Clathrin_H-chain/VPS_repeat | 5.37e-04 | 8 | 83 | 2 | IPR000547 | |
| Domain | EGF_CA | 5.84e-04 | 86 | 83 | 4 | PF07645 | |
| Domain | EGF | 6.27e-04 | 235 | 83 | 6 | SM00181 | |
| Domain | VWC | 6.38e-04 | 38 | 83 | 3 | SM00214 | |
| Domain | EGF-like_dom | 8.47e-04 | 249 | 83 | 6 | IPR000742 | |
| Domain | VWF_dom | 8.57e-04 | 42 | 83 | 3 | IPR001007 | |
| Domain | ZF_PHD_1 | 8.83e-04 | 96 | 83 | 4 | PS01359 | |
| Domain | TIL | 1.25e-03 | 12 | 83 | 2 | PF01826 | |
| Domain | C8 | 1.25e-03 | 12 | 83 | 2 | PF08742 | |
| Domain | V-set | 1.37e-03 | 184 | 83 | 5 | PF07686 | |
| Domain | Unchr_dom_Cys-rich | 1.47e-03 | 13 | 83 | 2 | IPR014853 | |
| Domain | C8 | 1.47e-03 | 13 | 83 | 2 | SM00832 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.72e-03 | 14 | 83 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.72e-03 | 14 | 83 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.72e-03 | 14 | 83 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.72e-03 | 14 | 83 | 2 | PF08393 | |
| Domain | MT | 1.72e-03 | 14 | 83 | 2 | PF12777 | |
| Domain | AAA_8 | 1.72e-03 | 14 | 83 | 2 | PF12780 | |
| Domain | TIL_dom | 1.72e-03 | 14 | 83 | 2 | IPR002919 | |
| Domain | ATPase_dyneun-rel_AAA | 1.72e-03 | 14 | 83 | 2 | IPR011704 | |
| Domain | AAA_5 | 1.72e-03 | 14 | 83 | 2 | PF07728 | |
| Domain | DHC_fam | 1.97e-03 | 15 | 83 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 1.97e-03 | 15 | 83 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 1.97e-03 | 15 | 83 | 2 | PF03028 | |
| Domain | VWD | 2.25e-03 | 16 | 83 | 2 | SM00216 | |
| Domain | VWF_type-D | 2.25e-03 | 16 | 83 | 2 | IPR001846 | |
| Domain | VWFD | 2.25e-03 | 16 | 83 | 2 | PS51233 | |
| Domain | VWD | 2.25e-03 | 16 | 83 | 2 | PF00094 | |
| Domain | VWC_out | 3.18e-03 | 19 | 83 | 2 | SM00215 | |
| Domain | EGF_3 | 3.96e-03 | 235 | 83 | 5 | PS50026 | |
| Domain | PHD | 4.54e-03 | 75 | 83 | 3 | PF00628 | |
| Domain | TUDOR | 4.65e-03 | 23 | 83 | 2 | PS50304 | |
| Domain | EGF_1 | 5.58e-03 | 255 | 83 | 5 | PS00022 | |
| Pathway | REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS | 2.24e-07 | 12 | 67 | 4 | M27738 | |
| Pubmed | 1.36e-08 | 3 | 84 | 3 | 22767497 | ||
| Pubmed | Primate-specific BTN3A2 protects against SARS-CoV-2 infection by interacting with and reducing ACE2. | 5.43e-08 | 4 | 84 | 3 | 39142074 | |
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 29339503 | ||
| Pubmed | The cluster of BTN genes in the extended major histocompatibility complex. | 4.72e-07 | 7 | 84 | 3 | 11170752 | |
| Pubmed | SLX4IP acts with SLX4 and XPF-ERCC1 to promote interstrand crosslink repair. | 1.39e-06 | 34 | 84 | 4 | 31495888 | |
| Pubmed | Receptor tyrosine kinases expressed in metastatic colon cancer. | 5.76e-06 | 2 | 84 | 2 | 7896447 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 34168658 | ||
| Pubmed | Differential role for CD277 as a co-regulator of the immune signal in T and NK cells. | 5.76e-06 | 2 | 84 | 2 | 21918970 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 22846996 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 12404111 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 21113407 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 15591058 | ||
| Pubmed | A 1.1-Mb transcript map of the hereditary hemochromatosis locus. | 1.08e-05 | 18 | 84 | 3 | 9149941 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 28513615 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 31281542 | ||
| Pubmed | Deconstructing cold-induced brown adipocyte neogenesis in mice. | 1.73e-05 | 3 | 84 | 2 | 35848799 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 21779982 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 11342471 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 18347060 | ||
| Pubmed | Beclin1 Modulates Bone Homeostasis by Regulating Osteoclast and Chondrocyte Differentiation. | 1.73e-05 | 3 | 84 | 2 | 31074883 | |
| Pubmed | Mapping of a region within the N terminus of Jak1 involved in cytokine receptor interaction. | 1.73e-05 | 3 | 84 | 2 | 11468294 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 29463737 | ||
| Pubmed | cAMP induces autophagy via a novel pathway involving ERK, cyclin E and Beclin 1. | 1.73e-05 | 3 | 84 | 2 | 21750416 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 3.16e-05 | 248 | 84 | 6 | 24006456 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 27893714 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 9382921 | ||
| Pubmed | Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13. | 3.45e-05 | 4 | 84 | 2 | 21962518 | |
| Pubmed | 5.28e-05 | 272 | 84 | 6 | 31010829 | ||
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 10531356 | ||
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 11331882 | ||
| Pubmed | Loss of PRMT5 Promotes PDGFRα Degradation during Oligodendrocyte Differentiation and Myelination. | 5.74e-05 | 5 | 84 | 2 | 30057274 | |
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 14514732 | ||
| Pubmed | Cross-reactivity of anti-programmed death ligand 2 polyclonal antibody in mouse tissues. | 5.74e-05 | 5 | 84 | 2 | 23090063 | |
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 15525354 | ||
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 26876213 | ||
| Pubmed | 6.28e-05 | 172 | 84 | 5 | 23184937 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 7.25e-05 | 736 | 84 | 9 | 29676528 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 8.47e-05 | 583 | 84 | 8 | 29844126 | |
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 28886382 | ||
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 30335599 | ||
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 28267575 | ||
| Pubmed | BTN1A1, the mammary gland butyrophilin, and BTN2A2 are both inhibitors of T cell activation. | 8.59e-05 | 6 | 84 | 2 | 20208008 | |
| Pubmed | Human cytomegalovirus UL138 interaction with USP1 activates STAT1 in infection. | 8.59e-05 | 6 | 84 | 2 | 37289831 | |
| Pubmed | 1.05e-04 | 601 | 84 | 8 | 33658012 | ||
| Pubmed | 1.08e-04 | 38 | 84 | 3 | 27141870 | ||
| Pubmed | Importin 8 is a gene silencing factor that targets argonaute proteins to distinct mRNAs. | 1.08e-04 | 101 | 84 | 4 | 19167051 | |
| Pubmed | CORO1A BTN3A3 CLTCL1 MIA2 GTF3C1 PDGFRA FNDC3A MSH3 EMD BTN3A2 TUFM | 1.15e-04 | 1168 | 84 | 11 | 19946888 | |
| Pubmed | 1.17e-04 | 103 | 84 | 4 | 10819331 | ||
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 38446206 | ||
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 9256245 | ||
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 20133701 | ||
| Pubmed | 1.44e-04 | 469 | 84 | 7 | 27634302 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | BMP1 HSPG2 UXS1 MIA2 GTF3C1 SYT12 PRMT5 ASPH LRP4 PRSS23 BTN3A2 | 1.47e-04 | 1201 | 84 | 11 | 35696571 |
| Pubmed | Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions. | 1.50e-04 | 110 | 84 | 4 | 37219487 | |
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 19559055 | ||
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 32878247 | ||
| Pubmed | 1.67e-04 | 1014 | 84 | 10 | 32416067 | ||
| Pubmed | Cleavage of nidogen-1 by cathepsin S impairs its binding to basement membrane partners. | 2.05e-04 | 9 | 84 | 2 | 22952693 | |
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 16224065 | ||
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 9484840 | ||
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 12676926 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | GTF3C1 PRMT5 ASPH PPP1R18 OAS3 EMD PRSS23 AJUBA SPEN TUFM TASOR2 | 2.18e-04 | 1257 | 84 | 11 | 36526897 |
| Pubmed | 2.56e-04 | 10 | 84 | 2 | 26300397 | ||
| Pubmed | PRMT5 is essential for B cell development and germinal center dynamics. | 2.56e-04 | 10 | 84 | 2 | 30604754 | |
| Pubmed | 3.13e-04 | 11 | 84 | 2 | 28628118 | ||
| Pubmed | Common variants on chromosome 6p22.1 are associated with schizophrenia. | 3.13e-04 | 11 | 84 | 2 | 19571809 | |
| Pubmed | 3.13e-04 | 11 | 84 | 2 | 18552835 | ||
| Pubmed | 3.13e-04 | 11 | 84 | 2 | 28714851 | ||
| Pubmed | Skp2 suppresses apoptosis in Rb1-deficient tumours by limiting E2F1 activity. | 3.13e-04 | 11 | 84 | 2 | 24632684 | |
| Pubmed | 3.13e-04 | 11 | 84 | 2 | 12447867 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | CCNE1 HSPG2 CLTCL1 KALRN KLHL21 KAT6A LRP4 ADGRL1 SPEN BTN3A2 | 3.31e-04 | 1105 | 84 | 10 | 35748872 |
| Pubmed | 3.75e-04 | 12 | 84 | 2 | 23569248 | ||
| Pubmed | 4.42e-04 | 13 | 84 | 2 | 26966181 | ||
| Pubmed | 4.42e-04 | 13 | 84 | 2 | 24550300 | ||
| Pubmed | 4.42e-04 | 13 | 84 | 2 | 37179372 | ||
| Pubmed | 5.09e-04 | 64 | 84 | 3 | 22865885 | ||
| Pubmed | Postnatal gene expression in the normal mouse cornea by SAGE. | 5.15e-04 | 14 | 84 | 2 | 14744882 | |
| Pubmed | 5.15e-04 | 14 | 84 | 2 | 18559345 | ||
| Pubmed | 5.15e-04 | 14 | 84 | 2 | 9373155 | ||
| Pubmed | BMP signaling mutant mice exhibit glial cell maturation defects. | 5.15e-04 | 14 | 84 | 2 | 17391983 | |
| Pubmed | Identification of a novel family of G protein-coupled receptor associated sorting proteins. | 5.15e-04 | 14 | 84 | 2 | 15086532 | |
| Pubmed | 5.15e-04 | 14 | 84 | 2 | 31346084 | ||
| Pubmed | 5.16e-04 | 152 | 84 | 4 | 34299191 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 5.71e-04 | 774 | 84 | 8 | 15302935 | |
| Pubmed | 5.93e-04 | 15 | 84 | 2 | 27829154 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 6.22e-04 | 430 | 84 | 6 | 35044719 | |
| Pubmed | Ontogeny of stromal organizer cells during lymph node development. | 6.77e-04 | 16 | 84 | 2 | 20237296 | |
| Pubmed | 6.77e-04 | 16 | 84 | 2 | 35714603 | ||
| Pubmed | 6.77e-04 | 16 | 84 | 2 | 20643125 | ||
| Pubmed | 6.77e-04 | 437 | 84 | 6 | 20562859 | ||
| Pubmed | 6.83e-04 | 608 | 84 | 7 | 16713569 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 6.83e-04 | 608 | 84 | 7 | 36089195 | |
| Pubmed | 7.66e-04 | 17 | 84 | 2 | 27862528 | ||
| Pubmed | 7.66e-04 | 17 | 84 | 2 | 21385873 | ||
| Pubmed | 8.19e-04 | 172 | 84 | 4 | 20628624 | ||
| Pubmed | Villification in the mouse: Bmp signals control intestinal villus patterning. | 8.60e-04 | 18 | 84 | 2 | 26721501 | |
| Pubmed | 9.60e-04 | 19 | 84 | 2 | 33422265 | ||
| Pubmed | The ciliary protein Ftm is required for ventricular wall and septal development. | 9.60e-04 | 19 | 84 | 2 | 23469020 | |
| Pubmed | 9.76e-04 | 80 | 84 | 3 | 28205554 | ||
| Pubmed | Identification of novel protein kinases expressed in the myocardium of the developing mouse heart. | 1.06e-03 | 20 | 84 | 2 | 7893599 | |
| Interaction | BTN3A3 interactions | 3.73e-06 | 26 | 83 | 4 | int:BTN3A3 | |
| Cytoband | 5p15.3 | 1.47e-04 | 10 | 84 | 2 | 5p15.3 | |
| GeneFamily | Butyrophilins|V-set domain containing|C2-set domain containing | 1.56e-07 | 15 | 61 | 4 | 458 | |
| GeneFamily | Dyneins, axonemal | 1.47e-03 | 17 | 61 | 2 | 536 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.13e-03 | 161 | 61 | 4 | 593 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 2.23e-03 | 163 | 61 | 4 | 590 | |
| GeneFamily | PHD finger proteins | 3.49e-03 | 90 | 61 | 3 | 88 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | BMP1 HSPG2 IGFBP2 KLHL21 LRP4 PPP1R18 ADGRL1 SHE IRX4 SORCS1 | 2.79e-06 | 479 | 83 | 10 | M2573 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | BMP1 HSPG2 IGFBP2 KLHL21 LRP4 PPP1R18 ADGRL1 SHE IRX4 SORCS1 | 3.01e-06 | 483 | 83 | 10 | MM1082 |
| Coexpression | GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP | 4.12e-05 | 199 | 83 | 6 | M4460 | |
| Coexpression | GSE22886_CTRL_VS_LPS_24H_DC_DN | 4.24e-05 | 200 | 83 | 6 | M4520 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP | 4.48e-05 | 202 | 83 | 6 | M38982 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 4.33e-09 | 200 | 84 | 8 | e504570fd7eec1524c401b1cfa9d10822d80d994 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-08 | 176 | 84 | 7 | c0a084f7a8645262d61971f094689e02bf15b113 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-08 | 176 | 84 | 7 | cccf9201f6e2da7524b911a5961d3b227edab222 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 4.37e-08 | 176 | 84 | 7 | 510f9a14dc1c151d24d079e0cc004cdf4f86336c | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.38e-08 | 186 | 84 | 7 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 7.65e-08 | 191 | 84 | 7 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.21e-08 | 193 | 84 | 7 | 316ebdf15f75d88c348f909b643fcd315364ca84 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.21e-08 | 193 | 84 | 7 | 1afdd3f7d703f4204a2cbfe40e135ac7b09213f7 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.21e-08 | 193 | 84 | 7 | 8dc6db335678f3a5cfd36026ad811fed8d9cb4bc | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 9.12e-08 | 196 | 84 | 7 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | 15-Airway-Mesenchymal-Mesenchyme_SERPINF1-high|Airway / Age, Tissue, Lineage and Cell class | 9.78e-08 | 198 | 84 | 7 | 3d76393e72eed59b4dd16130ef5dd1d331ba5711 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.01e-07 | 199 | 84 | 7 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-07 | 199 | 84 | 7 | 0019cfaa586a450c2e4952d1184a540561c8d0ba | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.05e-07 | 200 | 84 | 7 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-07 | 200 | 84 | 7 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-07 | 200 | 84 | 7 | 6e3d1ae0ef84d3075afa40129a41169996462672 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 1.05e-07 | 200 | 84 | 7 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 1.05e-07 | 200 | 84 | 7 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-07 | 170 | 84 | 6 | d7c9a604311974ff87ece43a0f8725a234d262f7 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 1.07e-06 | 177 | 84 | 6 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-06 | 181 | 84 | 6 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-06 | 189 | 84 | 6 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-06 | 189 | 84 | 6 | bc54ffd7bd1627a36747a80ce5139e4a69928400 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-06 | 190 | 84 | 6 | bd0d68dc1b6f388190a6ba8a83b011619abe2bdd | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-06 | 190 | 84 | 6 | e275de94468872e70cf305b3b450823d4c9c5e3f | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-06 | 190 | 84 | 6 | ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-06 | 190 | 84 | 6 | f3ca94a31a35eed5fecf3c4b8c957e1bc4150158 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-06 | 190 | 84 | 6 | c2cd1eb674162ee40502c3380b7245c85079c7ce | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-06 | 190 | 84 | 6 | 47077579496c5340e99f61499427a3a36b566da3 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-06 | 191 | 84 | 6 | a57cf0519d749febc0b69fe0b098b7ba53d63258 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-06 | 191 | 84 | 6 | 19c67a812b8ce97472d316acd15aeefe8736000d | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-06 | 192 | 84 | 6 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Vein|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-06 | 192 | 84 | 6 | 81baf1c4063469bb0c03a8602b40e387ba7b0dfb | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts-Subpleural_fibroblasts_L.2.1.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.72e-06 | 192 | 84 | 6 | 859a32c9e4ed6961897b2ccaecde73a599471df9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.72e-06 | 192 | 84 | 6 | 89e1da82fa2069dac7adb9cba3e8b6c0179e0dc5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-06 | 192 | 84 | 6 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-06 | 192 | 84 | 6 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Vein|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-06 | 192 | 84 | 6 | 717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 193 | 84 | 6 | 49600db68ed65cafc67bd45a285b364e4f5f88af | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 193 | 84 | 6 | 2d891c00b8f0aace17d4c300b63e2341dcffa199 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.77e-06 | 193 | 84 | 6 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 193 | 84 | 6 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-06 | 195 | 84 | 6 | 223f5f07dc28fa13a09bb589884c58043c7928c7 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-06 | 195 | 84 | 6 | 095b8e0be385b6390420589124a95fa4ba3682ab | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 1.88e-06 | 195 | 84 | 6 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-06 | 196 | 84 | 6 | 65f2f51e17f1869f3468813127b96d3048d8ad41 | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-06 | 196 | 84 | 6 | e4ed897900a6472738bc6be2fb4817192727225d | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.94e-06 | 196 | 84 | 6 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.94e-06 | 196 | 84 | 6 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.94e-06 | 196 | 84 | 6 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-06 | 196 | 84 | 6 | 2cd83176f2e8a9e6fa3c08cb33928a61e5fc43b6 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-06 | 196 | 84 | 6 | f47e551ba484687ba6ce8c29a085106131364042 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.94e-06 | 196 | 84 | 6 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.94e-06 | 196 | 84 | 6 | c35f2349dfe35baa845f790b9f31673dceac54c0 | |
| ToppCell | (1)_T_cells-(1)_T_CD8_CytT|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.94e-06 | 196 | 84 | 6 | 3a4ba9ca84ce6b35038765da8c55812587b58bc2 | |
| ToppCell | normal_Lung-T/NK_cells-NK|normal_Lung / Location, Cell class and cell subclass | 2.00e-06 | 197 | 84 | 6 | 6045a05a5f1073d683806eb46a3fa98358414625 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.06e-06 | 198 | 84 | 6 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-06 | 198 | 84 | 6 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 2.06e-06 | 198 | 84 | 6 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.06e-06 | 198 | 84 | 6 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.12e-06 | 199 | 84 | 6 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | medial-2-mesenchymal-Myofibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.12e-06 | 199 | 84 | 6 | 95aae608fa35a9c82b12c6f18937ce636750ca44 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.12e-06 | 199 | 84 | 6 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.12e-06 | 199 | 84 | 6 | fb23ecce41e31e2cc01814e3c0add756f489561f | |
| ToppCell | medial-mesenchymal-Myofibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.12e-06 | 199 | 84 | 6 | e25acdb5809aaff631cb06dbe4c7e59549a0bdb9 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.12e-06 | 199 | 84 | 6 | 655d07cf9a2fd9b945a2ed4f824cba0297de72a8 | |
| ToppCell | medial-mesenchymal-Myofibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.12e-06 | 199 | 84 | 6 | 9ebf4822ff9fa08574edec5dbf4f2a1488f34b1d | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_SERPINF1-high|Airway / Age, Tissue, Lineage and Cell class | 2.18e-06 | 200 | 84 | 6 | 14ae55660f7412518dcb5cb982f6fe9f23553cfb | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.18e-06 | 200 | 84 | 6 | 4f7e26b27bd51c32420ed8c2f52d070aee542159 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Myofibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.18e-06 | 200 | 84 | 6 | ca777a7d001848f6d01c613ff2bda7e4f3e20521 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.18e-06 | 200 | 84 | 6 | 44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f | |
| ToppCell | tumor_Lung-Fibroblasts|tumor_Lung / Location, Cell class and cell subclass | 2.18e-06 | 200 | 84 | 6 | 073a68b5ce232203ffee86342cba2a00d907e119 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.18e-06 | 200 | 84 | 6 | 16a3685c41194a0a4a772e4eee372160263480e0 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-06 | 200 | 84 | 6 | 3e0041c04e42a47257517dae8707a6454570c256 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-06 | 200 | 84 | 6 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | Biopsy_IPF-Mesenchymal-HAS1_High_Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 2.18e-06 | 200 | 84 | 6 | d02e256b5d65a5c982ba5696bc7e077281ca3e24 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.18e-06 | 200 | 84 | 6 | 1c10597edd532bf172ca09870a937d35e2585081 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.18e-06 | 200 | 84 | 6 | 440dda48b09c6a8581b7ca634b0d67f1ecacf65e | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast-MyoFB-3|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 5.76e-06 | 135 | 84 | 5 | 5b13ff740d9f7d96274aebb6b389a80f6004adc7 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.24e-05 | 158 | 84 | 5 | 9e0589f770920f8ac41cfe5cd0a29e9e7a04a308 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.28e-05 | 159 | 84 | 5 | 34c90711c5857cf6ada7b3acff99f1d48c7caf29 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 1.28e-05 | 159 | 84 | 5 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.28e-05 | 159 | 84 | 5 | 92049a8d8fc9997d8d0d76500c72596a9b2394e0 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_ALM_Oprk1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.40e-05 | 162 | 84 | 5 | 2d28306c6125b31f11ea6d911a167b93a74907c5 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 1.48e-05 | 164 | 84 | 5 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-05 | 167 | 84 | 5 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.66e-05 | 168 | 84 | 5 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.66e-05 | 168 | 84 | 5 | 26aa96b2b547d11941cb803995ea3d302ee0518c | |
| ToppCell | ASK454-Immune-NK_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.76e-05 | 170 | 84 | 5 | 84705434234bf2fbb5256bd5a1f6ab54c01c5a51 | |
| ToppCell | ASK454-Immune-NK_cell|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.86e-05 | 172 | 84 | 5 | c9e738c3540ee09b08805b1cdb66b4a0d9d40d33 | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.97e-05 | 174 | 84 | 5 | 2891ab2fd05eb4bbd239d1a2865f21ef7f2df39e | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.97e-05 | 174 | 84 | 5 | eade55f86ef1f7a5355ad65cec3aa6bfc5d3c62d | |
| ToppCell | droplet-Heart-HEART-1m-Hematologic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 175 | 84 | 5 | 43b9cfd7c47d57244565c641e57f3256b5900804 | |
| ToppCell | droplet-Heart-HEART-1m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 175 | 84 | 5 | a2fed97cf8d28f9936fe791e5e8c43d2430330c9 | |
| ToppCell | droplet-Heart-HEART-1m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-05 | 176 | 84 | 5 | 1df640f88667e2dad30e65279d6d33bba75024c1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.14e-05 | 177 | 84 | 5 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.14e-05 | 177 | 84 | 5 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.14e-05 | 177 | 84 | 5 | 946803293a7955116c80f403e99e4093e798ca3f | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.14e-05 | 177 | 84 | 5 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.14e-05 | 177 | 84 | 5 | d5aeda113afaa2425874394610344570c9078478 | |
| Computational | Neighborhood of SNRK | 1.23e-05 | 28 | 56 | 4 | GNF2_SNRK | |
| Computational | Neighborhood of ITGAL | 1.85e-04 | 55 | 56 | 4 | GNF2_ITGAL | |
| Computational | Neighborhood of CASP8 | 3.59e-04 | 27 | 56 | 3 | GNF2_CASP8 | |
| Disease | Childhood Medulloblastoma | 6.61e-06 | 43 | 83 | 4 | C0278510 | |
| Disease | Melanotic medulloblastoma | 6.61e-06 | 43 | 83 | 4 | C1275668 | |
| Disease | Medullomyoblastoma | 6.61e-06 | 43 | 83 | 4 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 6.61e-06 | 43 | 83 | 4 | C0751291 | |
| Disease | Adult Medulloblastoma | 6.61e-06 | 43 | 83 | 4 | C0278876 | |
| Disease | Medulloblastoma | 1.21e-05 | 50 | 83 | 4 | C0025149 | |
| Disease | hypertension (biomarker_via_orthology) | 4.47e-05 | 227 | 83 | 6 | DOID:10763 (biomarker_via_orthology) | |
| Disease | Hypereosinophilic syndrome | 4.67e-05 | 4 | 83 | 2 | C1540912 | |
| Disease | medulloblastoma (is_marker_for) | 7.77e-05 | 5 | 83 | 2 | DOID:0050902 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | CCNE1 BMP1 MIA2 KALRN ZSWIM5 BOD1L1 SPEN BTN3A2 TP73 CLASRP SORCS1 | 2.07e-04 | 1074 | 83 | 11 | C0006142 |
| Disease | Leydig cell tumor (is_marker_for) | 2.16e-04 | 8 | 83 | 2 | DOID:2696 (is_marker_for) | |
| Disease | Salivary Gland Neoplasms | 3.18e-04 | 47 | 83 | 3 | C0036095 | |
| Disease | T-cell acute lymphoblastic leukemia (is_implicated_in) | 4.23e-04 | 11 | 83 | 2 | DOID:5603 (is_implicated_in) | |
| Disease | gait measurement | 8.63e-04 | 150 | 83 | 4 | EFO_0007680 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 9.08e-04 | 264 | 83 | 5 | EFO_0008317, EFO_0020944 | |
| Disease | prostate cancer (is_marker_for) | 9.99e-04 | 156 | 83 | 4 | DOID:10283 (is_marker_for) | |
| Disease | complement factor H-related protein 3 measurement | 1.34e-03 | 169 | 83 | 4 | EFO_0600056 | |
| Disease | Hodgkins lymphoma | 1.62e-03 | 82 | 83 | 3 | EFO_0000183 | |
| Disease | seminoma (is_marker_for) | 1.74e-03 | 22 | 83 | 2 | DOID:4440 (is_marker_for) | |
| Disease | breast cancer (is_marker_for) | 1.87e-03 | 185 | 83 | 4 | DOID:1612 (is_marker_for) | |
| Disease | prostate carcinoma (is_marker_for) | 1.90e-03 | 23 | 83 | 2 | DOID:10286 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GPRACYDEGKRVAET | 226 | Q8NBZ7 | |
| CRGYREIPEGNEKAL | 221 | P43235 | |
| AESDEARRCYNDPKC | 201 | P08588 | |
| DGKEVEDRQSAPYRG | 81 | O00478 | |
| DGKEVEDRQSAPYRG | 81 | O00481 | |
| ARPSDDGQYRCLFEK | 331 | Q9UIR0 | |
| REPEAREDYFGTCIK | 326 | Q96IF1 | |
| ANYGRTDDKICDADP | 61 | O94910 | |
| ARLYFCEDRKAEPEG | 111 | Q9GZX7 | |
| EDDDRVYPNSTCKPR | 81 | P24864 | |
| RARYGKAQCEDDLAE | 376 | Q12797 | |
| GQPAKADQCYEDVRV | 16 | P31146 | |
| PGYELAPDKRRCEAA | 576 | P13497 | |
| EDSDREDGNYCPPVK | 106 | Q9H6Z4 | |
| APEDSGRYRCRVTNK | 3356 | P98160 | |
| FGKVELCRYDPEGDN | 886 | P23458 | |
| RNKCADEKRPYAEGE | 211 | P78413 | |
| DEECRQVYPGKITDN | 186 | Q9UKR3 | |
| CDQDLSNYDPKRGNR | 1606 | Q8N7Z5 | |
| GDYECAARQATREVK | 286 | P16234 | |
| AKQGDYCRPTVQEER | 841 | P20585 | |
| EEVEKGETRFCLPYR | 381 | Q14457 | |
| DRLNDDAKRYSCTPR | 261 | Q9GZP0 | |
| CEKRRDAEYGASPEQ | 131 | P18065 | |
| EYVDCSDPKAQRRTN | 1181 | Q7Z5P9 | |
| KGQDPDACDVYADSR | 106 | A0A1W2PR82 | |
| QTGECDPEEIYKAAR | 606 | O60229 | |
| KYCTPRHQDFDDLER | 106 | O94953 | |
| KYEEIDNAPEERARG | 91 | P49411 | |
| ERGPYCVDENTERRN | 231 | Q969F2 | |
| PKRYRDGCSEEQLRQ | 1301 | Q8IVE3 | |
| KNPGEEEEYRCEAKN | 186 | Q7Z6M3 | |
| PRAKVEDAGRYTCVA | 2836 | Q96RW7 | |
| ACPGRDRKADEDHYR | 296 | O15350 | |
| PDGRKARGEVVDYSE | 421 | Q92794 | |
| RRDCLADVDTKPAYQ | 71 | Q8NFC6 | |
| RDDGLCVPKEEAAYQ | 186 | Q9UJP4 | |
| TREDEGCYDPLEKLR | 151 | Q66K79 | |
| DEPATKRQSREYEDG | 606 | Q96AV8 | |
| ECNYGGRVTDDKDRR | 3731 | Q8TD57 | |
| KLDPQGAVRDCVYDR | 1081 | Q9Y6R7 | |
| KDEPREVYQGSEVEC | 706 | Q9Y2H6 | |
| YNEVRACREKDRDPE | 481 | O14744 | |
| DRKERYPSCEDQDLP | 356 | Q8TDC3 | |
| DGKEVEDRQSAPYRG | 81 | P78410 | |
| RAELKYDDNRPNRVC | 496 | Q7Z6J4 | |
| EGYREKRPCDSEESD | 1271 | Q05BV3 | |
| ECKDRERPMYGRDSA | 146 | P50402 | |
| CASVDEEGRKRIDSY | 2326 | Q9P225 | |
| GEERQDYSEECGRKE | 266 | Q6NYC8 | |
| AGEASPRQCRRYEVD | 81 | O15244 | |
| KYRDVAECGPQQELD | 101 | Q9BTE3 | |
| YCGDEDPRKAENREI | 161 | Q5VZ72 | |
| DKRGTKEDPRADYAC | 76 | O00453 | |
| NCFTDYKDQGPRRAE | 481 | Q9Y6K5 | |
| SSYRNECPRAEKEDT | 491 | A8MW92 | |
| EERDTPKLYCGADGD | 241 | Q9UF33 | |
| RGPDCRYLNFTKGEE | 51 | Q96PC5 | |
| EDCDYIVQKARERGA | 101 | P32754 | |
| YGESCAEAREKRVPA | 66 | Q8IV01 | |
| ARNPQYRAEGETCVE | 66 | Q8NFB2 | |
| ARNPRYRTEGEACVE | 66 | Q9H7F4 | |
| ECYERFSRETDGAQK | 196 | Q9UK53 | |
| CPVYKVSDRFRDAAE | 466 | Q96D09 | |
| RPGNLVYRFCDVKDE | 286 | O95084 | |
| DCSPADKPYIDEARR | 221 | Q96DG6 | |
| DSSVVGRYCEKRDPH | 901 | P53675 | |
| SPEQESDERKCNYER | 101 | Q8N2M8 | |
| FENSPDYCIRDREAG | 271 | P09544 | |
| PEGLYAQDKVCRNEE | 676 | Q9P217 | |
| GRDRKIYCTDLRNPD | 271 | Q8TAF3 | |
| DQGPEREDVRKNYCS | 1121 | Q96T58 | |
| DVVGRIAPCDEAYRK | 136 | Q8N431 | |
| NRFDLAKEYCRERPD | 406 | Q9P253 | |
| HTGERPYECSDREKA | 301 | Q7Z340 | |
| QYCEALADEENRARP | 281 | Q96MG7 | |
| GDCRNPRLDLEDSYT | 1836 | Q5VWN6 | |
| NPRQADYDKDEVGDR | 761 | P35442 | |
| MNRRGDYDDPKVCAN | 1351 | Q12789 | |
| KSIFDRRCAEEDYRP | 666 | Q8WY21 | |
| DPYDAKRTKGQRDAE | 206 | Q5VZ18 | |
| AERTPSVEKPYRCDD | 471 | O95125 | |
| RVPRSGDRVYKNECA | 36 | Q92995 | |
| ETGYELRPDRRSCKA | 421 | O75096 |